Anti-Müllerian hormone and luteinizing hormone for prediction of spontaneous ovulation after laparoscopic ovarian drilling in clomiphene-resistant polycystic ovary syndrome

Rezk, Mohamed; Emarh, Mohamed; Al-Halaby, Alaa

doi:10.1016/j.mefs.2015.09.003

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies have shown that preoperative high AMH concentrations could indicate the failure of induction of ovulation after LOD. According to some studies, the threshold varies from 7.7 ng/mL to 8.5 ng/mL [83,84] AMH in PCOS women undergoing in vitro fertilization (IVF) procedure. Numerous studies indicate the role of both low and high AMH in predicting IVF results [85][86][87][88].…”

Section: Amh and Ovarian Response In Women With Pcosmentioning

confidence: 99%

Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS

Rudnicka

Kunicki

Calik-Ksepka

et al. 2021

IJMS

View full text Add to dashboard Cite

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-aged women. It is characterized by chronic anovulation, hyperandrogenism, and the presence of polycystic ovary in ultrasound examination. PCOS is specified by an increased number of follicles at all growing stages, mainly seen in the preantral and small antral follicles and an increased serum level of Anti-Müllerian Hormone (AMH). Because of the strong correlation between circulating AMH levels and antral follicle count on ultrasound, Anti-Müllerian Hormone has been proposed as an alternative marker of ovulatory dysfunction in PCOS. However, the results from the current literature are not homogeneous, and the specific threshold of AMH in PCOS and PCOM is, therefore, very challenging. This review aims to update the current knowledge about AMH, the pathophysiology of AMH in the pathogenesis of PCOS, and the role of Anti-Müllerian Hormone in the treatment of this syndrome.

show abstract